Lupin Limited has informed the Exchange about press release dated 18-Aug-2022 titled Lupin Receives Approval from U.S. FDA for Rufinamide Tablets USP.
Lupin Limited has informed the Exchange about press release dated 18-Aug-2022 titled Lupin Receives Approval from U.S. FDA for Rufinamide Tablets USP.